Picture of Alkermes logo

ALKSV — Alkermes News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeLarge CapNeutral

Alkermes Plc expected to post earnings of 6 cents a share - Earnings Preview

* Alkermes Plc  ALKS.OQ   ALKS.O  is expected to show a rise in
quarterly revenue when it reports results on October 27. 
* The Dublin-based company is expected to report  a
13.7% increase in revenue to $301.356 million from $265.01
million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Alkermes Plc is for
earnings of 6 cents per share. For the same quarter last year,
the company reported earnings of 26 cents per share.
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 2 "strong buy" or "buy," 5
"hold" and 1 "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Alkermes Plc is
$26.5​, about 16.4% below​ its last closing price of $30.85. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 30 2021  0.15        0.12       0.30      Beat    147.1
 Mar. 31 2021  -0.02       -0.02      0.11      Beat    718.8
 Dec. 31 2020  0.07        0.07       0.10      Beat    40.8​
 Sep. 30 2020  0.01        0.00       0.26      Beat    12,900
 Jun.          0.03​       -0.01      0.06      Beat    600​
 30​ 2020​                                              
 Mar. 31 2020  -0.08       -0.06      0.01      Beat    116.7​
 Dec. 31 2019  0.66        0.65       0.83      Beat    27.9
 Sep. 30 2019  -0.20       -0.21      -0.04     Beat    80.6
 This summary was machine generated October 25 at 15:43 GMT.  All
figures in US dollars unless otherwise stated

Recent news on Alkermes

See all news